Clinical Trial Update: Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial update involving a monoclonal antibody therapy, combination chemotherapy, and peripheral stem cell transplant in lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: University of Nebraska | Conditions: Lymphoma | Phase 2 | Status: COMPLETED